Latest news
Stoke Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:STOK) 2026-08-07 - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 00:20:19 GMTAnalysts Have Made A Financial Statement On Stoke Therapeutics, Inc.'s (NASDAQ:STOK) Second-Quarter Report - simplywall.stsimplywall.st · Thu, 06 Aug 2026 12:23:47 GMTStoke Therapeutics (STOK) CMO sells 7,176 shares under 10b5-1 plan - Stock TitanStock Titan · Wed, 05 Aug 2026 20:18:08 GMTAnalysts Are Bullish on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Stoke Therapeutics (STOK) - The Globe and MailThe Globe and Mail · Wed, 05 Aug 2026 16:18:00 GMTStoke Therapeutics to Present at the Canaccord Genuity 46th Annual Growth Conference - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:00:00 GMTStoke Therapeutics Expands ATM Equity Program for Funding - The Globe and MailThe Globe and Mail · Tue, 04 Aug 2026 22:26:00 GMTThese Analysts Revise Their Forecasts On Stoke Therapeutics After Q2 Results - BenzingaBenzinga · Tue, 04 Aug 2026 13:28:05 GMTWedbush Adjusts Price Target on Stoke Therapeutics to $40 From $38, Maintains Outperform Rating - MoomooMoomoo · Tue, 04 Aug 2026 12:18:55 GMT